Stop parsing PDFs. Get the API. Request Access

AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

El.En.

Investor Presentation • Nov 23, 2016

4393_cp_2016-11-23_69210b18-3d6b-448b-a011-499aa3252368.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

COMPANY PRESENTATION

9M 2016 FINANCIAL RESULTS

INTERMONTE

Nov. 23rd2016

Disclaimer

Certain statements in this slide show, including those addressing the Company's beliefs, plans, objectives, estimates or expectations of possible future results or events, are forward-looking statements. Forward-looking statements involve known or unknown risks, including general economic and business conditions, and conditions in the industry we operate and may be affected should our assumptions turn out to be inaccurate. Consequently, no forward-looking statement can be guaranteed and actual future results, performance, or achievements may vary materially from those expressed or implied by such forward-looking statements. The Company undertakes no obligation about the contents nor to update the forward-looking statements to reflect events or circumstances that may arise after the date hereof.

Summary

  • 1.LASER: APPLICATIONS AND MARKETS
  • 2.EL.EN. GROUP
  • 3.9 MONTHS 2016 FINANCIAL RESULTS
  • 4.2016 TARGETS
  • 5.EL.EN. STOCK, MULTIPLES & COMPARABLES

Laser: Applications and Markets

LASER

Light Amplification by Stimulated Emission of

Radiation

Medicaland Aest. Applications

Surgical Laser systems

Aesthetic Laser systems

Industrial Laser systems

The MEDICAL Laser Market

k
S
M
t
t
a
r
e
e
g
m
e
n		 2
0
1
4		 2
0
9
1		 G
%
C
A
R
2
0
1
4
2
0
1
9
-
l
S
i
u
r
g
c
a		 8
1
3		 1
2
1
9		 %
8
4
,
C
i
t
o
s
m
e
c		 1
0
2
4		 2
0
9
7		 1
5
4
%
,
l
D
t
e
n
a		 2
4
4		 6
2
3		 %
2
0
7
,
i
V
t
e
e
r
n
a
r
y		 1
1
5		 2
4
7		 %
1
6
5
,
l
T
t
o
a		 2
1
9
5		 4
1
8
5		 %
1
3
8
,

Source: BCC research

The INDUSTRIAL Laser Market

Global market and forecast for high power laser systems, by application (by value)

l
V
B
y
a
u
e		 (
)
C
A
G
%
R
2
0
1
6		 2
0
2
0		 2
0
1
3
2
0
1
6
-		 2
0
1
6
2
0
2
0
-
i
C
t
t
n
g
u		 3
0
1
4		 3
9
6
5		 7
8
,		 7
1
,
l
d
d
i
i
W
B
e
n
g
a
n
r
a
n
g
z		 6
0
1
5		 2
2
3
1		 8
7
,		 8
6
,
f
d
h
S
O
t
t
t
t
u
r
a
c
e
r
e
a
m
e
n
a
n
e
r		 6
3		 8
6		 8
3
,		 8
1
,
l
T
t
o
a		 4
6
8
2		 6
2
8
2		 8
1
,		 7
6
,

El.En. Group

Group Overview

High –Tech laser photonics Group

Develops, manufactures and distributes on a global basis laser sources and laser systems for medical and industrial applications

Know-how based on 35 years stratification of multidisciplinary experience

FY 2015: Consolidated Revenue at €218 mln, up 21% YoY 9M 2016: Consolidated Revenue at €180 mln, up 15% YoY

1060 employees

Strategic Strengths

Multidisciplinary and multifacility R&D activity: sources, systems, applications

Industrial

Combine High tech laser source development with flexible production facilities focusing on application

Medical

Technological and clinical innovation improving performances and broadening the application scope of our laser systems

  • New applications
  • Improved efficacy and effectiveness of current applications

Leverage worldwide distribution with multi brand approach

Consolidated Revenuesand EBIT

R&D Activity

Clinical trials and validations of new therapeutic laser treatments and research on new applications of laser- tissue interaction

Broadening Mona Lisa Touch Clinical studiesNew Pico second laser platform Clinical studies on cutaneous ulcers Painless laser hair removalPatents developmentIncreased power of RF laser sourcesInnovative applications for mid power laser systems

New factory in Samarate…..

…and in Wenzhou(PRC)

9 Months 2016 Financial Results

ConsolidatedP&L – 9 MONTHS

/
0
0
0
E
u
r
o		 /
/
3
0
0
9
1
5		 /
/
3
0
0
9
1
6		 %
V
a
r.
R
e
v
e
n
u
e
s		 1
5
6
0
0
6		 1
0
0
0
%
,		 1
7
9
5
6
5		 1
0
0
0
%
,		 1
1
%
5
,
i
G
r
o
s
s
m
a
r
n
g		 0
2
3
6
7		 %
4
5
0
,		 8
6
2
3
7		 %
4
3
8
,		 %
1
1
9
,
i
O
E
t
p
e
r
a
n
g
x
p
e
n
s
e
s		 2
0
8
9
7		 %
1
3
3
,		 2
2
8
7
5		 %
1
2
7
,		 %
1
0
0
,
f
f
S
t
a
e
s
p
e
n
s
e
s		 3
0
1
3
6		 1
9
3
%
,		 3
2
7
8
5		 1
8
3
%
,		 8
8
%
,
E
B
I
T
D
A		 9
3
0
1
1		 %
1
2
4
,		 2
2
9
6
2		 %
1
2
8
,		 %
1
8
9
,
l
D
t
e
p
r.
a
m
o
r
a
c
c
r
u
a
s
.,
,		 3
1
1
7		 2
0
%
,		 3
1
9
3		 1
8
%
,		 2
%
4
,
E
B
I
T		 6
9
3
1
1		 1
0
4
%
,		 9
6
9
1
7		 1
1
0
%
,		 2
2
1
%
,
(
)
f
h
i
i
N
t
e
n
a
n
c
n
c
o
m
e
c
a
r
g
e
s		 8
8
1		 %
0
6
,		 (
)
6
7
5		 %
0
4
-
,
(
)
h
i
O
t
t
e
r
n
c
o
m
e
e
x
p
e
n
s
e
n
e		 1
1
7		 0
1
%
,		 2
2
9
3
3		 1
2
8
%
,		 1
9
4
4
4
0
%
,
E
B
T		 9
1
7
1
1		 %
1
1
0
,		 2
0
2
4
7		 %
2
3
4
,		 %
1
4
4
5
,

ConsolidatedP&L – Q3

Q
3
1
5
0
-		 Q
3
1
6
-		 %
V
a
r.
4
9
1
2
2		 1
0
0
0
%
,		 5
9
3
8
9		 1
0
0
0
%
,		 2
0
9
%
,
2
2
1
5
9		 4
1
%
5
,		 2
5
3
5
8		 4
2
%
7
,		 1
4
4
%
,
6
1
4
7		 2
%
1
5
,		 7
4
2
9		 2
%
1
5
,		 2
0
9
%
,
9
2
3
1		 8
8
%
1
,		 1
0
3
4
5		 %
1
7
7
,		 %
1
4
1
,
6
8
1
7		 3
8
%
1
,		 3
9
7
5		 2
%
1
5
,		 9
%
1
,
9
6
2		 2
0
%
,		 1
1
0
5		 9
%
1
,		 9
%
1
5
,
8
9
5
1		 8
%
1
1
,		 6
2
6
4		 0
%
1
5
,		 3
%
7
,
(
)
3
4
1		 %
0
7
-
,		 (
)
2
1
1		 %
0
4
-
,		 %
3
8
1
-
,
8
1		 %
0
0
,		 3
1		 %
0
0
,		 %
2
7
4
-
,
9
6
5
4		 1
1
2
%
,		 6
0
8
4		 1
0
2
%
,		 1
0
0
%
,

Net financial position and CapexEuro '000 31/12/15 30/09/16 Net financial position : 29.815 72.222 Financial invest. m/l term: 10.643 10.798 Dividend paid 6.384 Proceeds from Cyno shares sale 39.880Euro '000 30/09/15 30/09/16 Q3/16 Capex 4.934 9.552 5.042Buildings, lands & plants 3.100 8.100 4.600 Others1.834 1.452 442

2016Targets

2016 Guidance

Sales 2016 = Sales 2015 +10%-> €239 mln

EBIT 2016 = EBIT 2015 +15%-> €25 mln

El.En. Stock, Multiples & Comparables

El.En. Stock

El.En. Multiples

k
h
l
d
's
h
i
S
E
t
t
o
o
e
r
q
p
e
r
s
a
r
e
c
u
y		 9
/
k
l
d
i
j.
P
B
V
A
r
c
e
o
o
a
e
u		 2
3
,
/
(
)
E
V
E
B
I
T
8
5
%
E
B
I
T		 1
4
6
,
/
l
(
l
)
E
V
S
8
5
%
S
a
e
s
a
e
s		 1,
6
l.
k
C
E
E
M
t
n
a
r
e
a
p		 0
@
€
2
2
4
1
1
1,
5
,
f
l
i
i
i
i
N
t
t
e
n
a
n
c
a
p
o
s
o
n		 /
/
2
2
@
3
0
0
9
6
7
1
,
/
l
l
i
i
i
F
t
t
t
n
a
n
c
a
n
v
e
s
m
e
n
s
m
e
r
m		 /
/
@
1
0
8
3
0
0
9
1
6
,
i
l
E
V
t
n
e
r
p
r
s
e
a
u
e		 3
2
7
1
,

El.En. Comparables

h,
Se
3
0
2
0
1
6
t.
t
p
/
d
ica
l
he
ic
M
Ae
t
t
e
s		 ice
Pr		 Re
ve
nu
e		 %
Va
r.
Re
ve
nu
e		 E
B
I
T		 %
E
B
I
T		 M
K.
Ca
p.		 E
V		 /
Sa
le
E
V
s
(
*)		 /
E
V
E
B
I
T
(
*)		 /
(
*)
P
E		 /
k
P
Bo
o
lu
Va
e
Sy
ne
ro
n		 \$
7,
9
0		 \$
2
1
5.
2
1
0		 8
%		 \$
3.
0
0
2		 1
%		 \$
2
7
0.
7
0
0		 \$
1
8
7.
8
0
5		 0,
7		 4
6,
9		 1
8
8,
0		 1,
3
l
Ze
iq
t		 \$
4
2,
7
7		 \$
2
4
9.
0
9
1		 4
1
%		 \$
(
)
3.
0
3
4		 -1
%		 \$
1.
7
6
0.
0
0
0		 \$
1.
6
9
8.
5
5
2		 5,
1		 n.
a.		 n.
a.		 1
4,
4
Cu
te
ra		 \$
0
1
4,
7		 \$
8
0.
8
1
1		 2
%
4		 \$
(
)
2.
0
8
4		 -3
%		 \$
9
9.
8
9
0
1		 \$
3.
0
1
5
5
7		 1,
4		 n.
a.		 n.
a.		 3,
8
io
las
B
e		 \$
1,
7
1		 \$
3
8.
0
4
9		 %
1
2		 \$
(
)
1
0.
8
4
8		 %
-2
9		 \$
1
2
4.
9
8
0		 \$
1
1
2.
1
1
1		 2,
2		 n.
a.		 n.
a.		 4,
8
Cy
no
su
re		 \$
4
3,
6
5		 \$
3
1
1.
3
9
3		 3
1
%		 \$
2
3.
1
1
3		 7
%		 \$
1.
0
8
0.
0
0
0		 \$
8
8
3.
6
6
8		 2,
1		 2
8,
7		 6
0,
7		 2,
4
du
ia
l
In
tr
s
ho
ics
I
P
G
P
Co
to
n		 \$
9
6,
0
8		 \$
7
2
6.
0
5
2		 7
%		 \$
2
5
9.
1
1
3		 3
6
%		 \$
5.
1
5
0.
0
0
0		 \$
4.
3
8
0.
6
6
0		 4,
5		 1
2,
7		 2
0,
8		 3,
4
du
Pr
im
In
ie
tr
a
s		 €
1
4,
0
9		 €
2
7
4.
5
3
6		 6
%		 €
1
2.
3
1
6		 4
%		 €
1
4
6.
1
4
0		 €
2
6
8.
3
9
2		 0,
7		 1
6,
3		 1
9,
5		 1,
1
(
)
l.
E
En
1		 €
2
1,
2
5		 €
1
7
9.
5
6
5		 %
1
5		 €
1
9.
7
6
9		 %
1
1		 €
4
1
0.
0
7
1		 €
3
2
7.
0
5
1		 1,
6		 1
4,
6		 1
0,
9		 2,
3
(
)
d
l
ip
l
ie
1
E
V
t
an
m
u
s a
(
)
b
d e
Re
E
i
t a
ve
nu
e,
n
/
(
*
)
im
in
t
w
o o
ne
e
co		 fo
io
s
r p
re
v
in
ar
n
g
s a
nn
m
e		 l
i
de
us
s
l
d
ize
ua		 (
2
7,
2		 **
)

El.En. SPA

Enrico ROMAGNOLI Investor Relations Managertel. +39 055-8826807E-mail: [email protected]

POLYTEMS HIR SRL

Bianca FERSINI MASTELLONI Financial CommunicationTel. +39 06-6797849 / +39 06-69923324E-mail: [email protected]

POLYTEMS HIR SRL

Silvia MARONGIUPress officeTel. +39 06-6797849 / +39 06-69923324E-mail: [email protected]

More from El.En.

Regulatory Filings 2025
Dec 22
Transaction in Own Shares 2025
Dec 22
Share Issue/Capital Change 2025
Dec 22
Transaction in Own Shares 2025
Dec 3
Investor Presentation 2025
Dec 3
Report Publication Announcement 2025
Dec 3
Report Publication Announcement 2025
Dec 3
Registration Form 2025
Nov 28
Share Issue/Capital Change 2025
Nov 28
Share Issue/Capital Change 2025
Nov 28
View all filings →

Talk to a Data Expert

Have a question? We'll get back to you promptly.